Ethermed provides an intelligent automation platform that uses advanced language models and clinical reasoning to review documentation, interpret payer rules, and generate compliant prior-authorization submissions in seconds. The platform integrates with EHRs and payer systems and has processed millions of prior-authorization transactions. Ethermed reports a growing customer base, including nine customers prior to the Series A, and measurable reductions in denials and staff workload. CEO and co-founder Dan Friedman emphasizes amplifying clinical judgment through automation that understands medicine. The company plans to expand its data science and engineering teams and deepen partnerships with national health systems. Ethermed positions its technology to reduce administrative burden, improve accuracy, and speed access to care.

Total raised

$9M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2026